Abstract
Continuous aging of the population, growing health consciousness, and continuous technological advances have fueled the rapid rise in health-care costs in the United States and Europe for the past several decades. The exact impact of new medical technology on long-term spending growth remains subject to some controversy. By all measures, it is apparent that new medical technology is the dominant driver of increases in health-care costs and hence insurance premiums. This chapter addresses the impact of medical technology such as MRI-PET on health-care delivery systems with regard to medical practice and cost. Factors addressing the growth of medical technology will be explored before attempting to provide a means for assessing the effectiveness of medical technology. Finally, avoidable health-care cost drivers will be identified, and relating policy issues will be discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Centers for Medicare and Medicaid Services, Office of the Actuary, National Health Statistics Group. http://www.cms.hhs.gov/NationalHealthExpendData/. Accessed Sept 28, 2013.
Nichols LM. Can defined contribution health insurance reduce cost growth? EBRI issue brief, vol. 246. Washington, DC: Employee Benefit Research Institute; 2002.
Medtap International Inc.: The value of investment in health care: better care, better lives; 2004:14–21.
Rettig RA. Medical innovation duels cost containment. Health Aff. 1994;13(3):7–27.
Dietlein M, Weber K, Gandjour A, et al. Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany. Eur J Nucl Med. 2000;10:1441–56.
Dietlein M, Weber K, Gandjour A, et al. Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results. Eur J Nucl Med. 2000;11:1598–609.
Anderson GF, Frogner BK, Johns RA, Reinhardt UE. Health care spending and use of information technology in OECD countries. Health Aff. 2006;25(3):819–31.
Newhouse JP. Medical care costs: how much welfare loss? J Econ Perspect. 1992;6(3):3–21. For a thorough discussion of the components of health care spending growth and medical technology’s significant role, see the report of the Technical Review Panel on the Medicare Trustees Reports, Review of Assumptions and Methods of the Medicare Trustees’ Financial Projections (December 2000).
Cutler DM, Rosen AB, Vijan S. The value of medical spending in the United States, 1960–2000. N Engl J Med. 2006;355(9):920–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Goyen, M. (2014). Health-Care Costs and Impacts. In: Carrio, I., Ros, P. (eds) PET/MRI. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40692-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-40692-8_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40691-1
Online ISBN: 978-3-642-40692-8
eBook Packages: MedicineMedicine (R0)